Clinical Trials: Vendor Contract Management

Managing Contract Expirations and Renewals

Posted on digi By digi

In the lifecycle of clinical trials, vendor contracts govern the responsibilities, performance standards, and financial obligations of CROs, laboratories, and technology partners. These contracts are typically time-bound. If they expire without proper renewal, sponsors face critical risks such as halted trial activities, non-compliance with ICH-GCP, inability to process invoices, and legal disputes. Regulators increasingly expect sponsors to demonstrate proactive management of contract expirations and renewals. The EU Clinical Trial Regulation (CTR 536/2014) and ICH-GCP E6(R2) emphasize vendor oversight and accountability throughout the trial, including contract continuity. This makes expiration and renewal management not only an operational necessity but also a compliance requirement. This article explores structured approaches to managing expirations and renewals using CTMS, governance processes, and negotiation strategies, ensuring trial continuity and regulatory readiness.
Click to read the full article.

Outsourcing and Vendor Management, Vendor Contract Management

Common Legal Pitfalls in Trial Vendor Agreements

Posted on digi By digi

Vendor agreements in clinical trials are not merely financial instruments; they are legal frameworks that govern accountability, compliance, and performance. A well-drafted contract mitigates risks, ensures regulatory alignment, and clarifies responsibilities. However, many sponsors encounter legal pitfalls that create vulnerabilities during trial execution or regulatory inspection. These pitfalls often result in disputes, budget overruns, and compliance findings. This article identifies common contract pitfalls, illustrates them with real-world case studies, and provides strategies for drafting agreements that stand up to legal and regulatory scrutiny.
Click to read the full article.

Outsourcing and Vendor Management, Vendor Contract Management